CannabisNewsBreaks – BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE:7BC) Leveraging State-of-the-Art Facilities, Expertise in Rapidly Growing Market

BevCanna Enterprises (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC), a diversified health and wellness beverage and natural products company, is in a position to leverage its state-of-the-art facilities and expertise to manufacture its own beverage product lines and to provide white-label solutions to a growing list of third-party companies. This comes as a recent Expert Market Research (“EMR”) report projects that North America is likely to be the fastest-growing and largest marketplace for cannabis beverages and that the global market will grow at a 48% CAGR in the next five years. Thus, BevCanna is ideally situated. A recent article reads, “The report noted that increasing demand for wellness beverages is expected to drive the expansion of cannabis beverage industry. ‘Cannabis beverages are predicted to exchange other marijuana-infused consumables, like chocolate, cookies, brownies and confectionaries like gummies and candies, which are considered to be not healthy. This factor is predicted to spice up the demand for cannabis drinks over the forecasted period.’”

To view the full article, visit https://cnw.fm/CEj3I

About BevCanna Enterprises Inc.

BevCanna Enterprises is a diversified health and wellness beverage and natural products company. BevCanna develops and manufactures a range of alkaline, plant-based and cannabinoid beverages and supplements for both in-house brands and white-label clients. With decades of experience creating, manufacturing and distributing iconic brands that resonate with consumers on a global scale, the team demonstrates an expertise unmatched in the nutraceutical and cannabis-infused beverage categories. Based in British Columbia, Canada, BevCanna owns a pristine alkaline spring water aquifer and a world–class 40,000–square–foot, HACCP-certified manufacturing facility, with a bottling capacity of up to 210M bottles annually. BevCanna’s extensive distribution network includes more than 3,000 points of retail distribution through its market-leading TRACE brand, its Pure Therapy natural health and wellness e-commerce platform, its fully licensed Canadian cannabis manufacturing and distribution network, and a partnership with top U.S. cannabis beverage company Keef Brands. For more information about the company, visit www.BevCanna.com.

NOTE TO INVESTORS: The latest news and updates relating to BVNNF are available in the company’s newsroom at http://cnw.fm/BVNNF

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Impressive Findings of Oral THC Absorption Study

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced that its recent oral tetrahydrocannabinol (“THC”) absorption study THC-A21-1 revealed that DehydraTECH(TM)-THC delivered via oral ingestion required only 15 minutes to deliver THC levels in blood plasma comparable to levels achieved at 45 minutes with concentration-matched controls. According to the update, DehydraTECH-THC delivered more THC into the bloodstream during the study than the industry standard medium chain triglyceride (“MCT” or “coconut oil”) based control formulation from the two-minute mark onwards, then dropped rapidly to the same level as the MCT control by the six-hour mark. “The cannabis industry continues to use outdated formulations and processes that ignore the needs of modern THC users,” said Chris Bunka, CEO of Lexaria Bioscience Corp. “THC users today include recreational, medicinal and pharmaceutical users, all of whom need technology that doesn’t rely on harmful delivery methods such as smoking but still provides rapid onset and high bioavailability, which common oral formats do not offer. Our study findings demonstrated rapid delivery, increased overall THC delivery, and higher brain tissue delivery; all of which is consistent with the wants and needs of THC customers.”

To view the full press release, visit https://cnw.fm/FZGqH

About Lexaria Bioscience Corp.

Lexaria’s patented drug delivery technology, DehydraTECH(TM), improves the way active pharmaceutical ingredients (“APIs”) enter the bloodstream by promoting more effective oral delivery. Since 2016, DehydraTECH has repeatedly demonstrated the ability to increase bio-absorption with cannabinoids and nicotine by up to 5-10x, reduce time of onset from 1-2 hours to minutes and mask unwanted tastes; it is also being evaluated for orally administered anti-viral drugs, non-steroidal anti-inflammatory drugs (“NSAIDs”) and more. DehydraTECH has also evidenced an ability to deliver some drugs more effectively across the blood brain barrier. Lexaria operates a licensed in-house research laboratory and holds a robust intellectual property portfolio with 21 patents granted and over 50 patents pending worldwide. For more information, visit the company’s website at www.LexariaBioscience.com.

NOTE TO INVESTORS: The latest news and updates relating to LEXX are available in the company’s newsroom at https://cnw.fm/LEXX

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Grapefruit USA Inc. (GPFT) to Move Forward with Regulatory Approval Process to Bring Hourglass(TM) to All Canadians

Grapefruit USA (OTCQB: GPFT), a premiere California-based cannabis and hemp company, today announced its entry into a formal collaboration with 6PAK Solutions Inc. and Medz Cannabis, Inc., 6PAK’s partner and license holder, to bring Grapefruit’s patented Hourglass(TM) Time Release THC+CBD Delivery Topical Relief Cream to market throughout Canada. According to the update, the formal collaboration agreement cements the strategic alliance with 6PAK Solutions Inc., a well-respected Canadian cannabis manufacturer and arm of ATG Pharma Inc. Under the new alliance, Grapefruit will file its Notice of New Cannabis Product (“NNCP”) with Health Canada detailing the Hourglass production process, including integration of the patented Z-Pod Xerogel Silica Gel technology into the Hourglass topical delivery cream system. “We are very pleased to have entered into the formal agreement with 6PAK and its licensed partner Medz Cannabis to cement our strategic alliance and immediately move forward with obtaining Canadian regulatory approval to bring Grapefruit’s patented time-release THC+CBD topical delivery cream to all Canadians. As I have stated before, 6PAK Solutions’ expertise in this area is unrivaled and assures Grapefruit will bring a fully compliant cannabis product to market in Canada,” said Bradley J. Yourist, Grapefruit’s CEO and co-founder. “6PAK is also a subsidiary of ATG Pharma Inc., a leader in regulatory compliant filling and packaging for the cannabis industry in Canada, so we are in good hands indeed. Our team looks forward to working with Chris Shar and his team in the coming weeks to achieve our corporate goal of introducing Hourglass across the entire nation of Canada in the second quarter of 2022. We expect this experience in Canada will be make it easier for Grapefruit to replicate the process in the United States when cannabis is finally de-scheduled from the list of U.S. federally controlled substances.” To view the full press release, visit https://cnw.fm/vJ4tD About Grapefruit USA Inc. Grapefruit’s corporate headquarters is in Westwood, Los Angeles, California. Grapefruit holds California permits and licenses to both manufacture and distribute cannabis products in the Golden State. Grapefruit’s extraction laboratory and manufacturing and distribution facilities are located in the industry-recognized Coachillin’ Industrial Cultivation and Ancillary Canna-Business Park in Desert Hot Springs, located on the extension of North Canyon Road, approximately 14 miles north of downtown Palm Springs. For more information about the company, visit www.GrapefruitBlvd.com. NOTE TO INVESTORS: The latest news and updates relating to GPFT are available in the company’s newsroom at https://cnw.fm/GPFT    About CannabisNewsWire CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge. To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only) For more information please visit https://www.CannabisNewsWire.com Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer Do you have questions or are you interested in working with CNW? Ask our Editor CannabisNewsWire (CNW) Denver, Colorado www.CannabisNewsWire.com 303.498.7722 Office Editor@CannabisNewsWire.com CannabisNewsWire is part of the InvestorBrandNetwork.

420 with CNW — Safeguards Marijuana Extractors Should Consider for Facilities

Processors usually use different methods to extract marijuana. While there is a lot that goes into this, safety should be a top priority at all times. Natvana’s CEO Casey Flippo states that extraction laboratories should implement the applicable safety standards for the method of extraction they use.

The most common methods of extraction include:

  • Rosin, which is regarded as the safest method of extraction. However, individuals should be careful as burns are possible
  • Ethanol is another extraction method that can create a flash point if too much vapor leaks into the air. The method is also highly flammable
  • Carbon dioxide extraction is another method used by processors, which is dangerous if a leak occurs as it puts individuals at risk of carbon monoxide poisoning
  • Hydrocarbon extraction is regarded as the most dangerous method of extraction as it could blow up if the flammable solvents utilized leak and are ignited

Other health hazards in marijuana production include eye and skin exposure to harsh cleaning products and chemicals, hearing loss from being around extremely loud equipment and the breathing of marijuana dust. It should be noted that properly run laboratories that have been designed and built in the proper way have significantly decreased safety risks.

Below are a few factors processors should consider when establishing a new facility to ensure that safety is upheld.

Personal protective equipment

Essential Extracts founder Nick Tanem states that personal protective equipment should always be worn at all times in the laboratory, regardless of whether the facility uses solventless or hydrocarbon methods of extraction. He notes that the PPE also helps keep products safe from contamination and the laboratories clean. This equipment includes eyewear, nitrile powder-free gloves and ear protection.

Employee training

Managing partner of Illuminated Extractors JD Garrick states that it is important to ensure that all employees are trained in all processes and products used in the lab, in addition to following the Occupational Safety and Health Administration standards.

Proper facility design

The chief brand officer of Spirits Extraction Products Liz Geisleman states that having a proper facility design can ward off accidents. She adds that having proper ventilation located in the right spots is also a must, as some gases are heavier than others.

Garrick adds that having a third-party certified engineer take a look at design plans before construction can begin will make certain that someone has acknowledged that the premises will be safe to work in.

When medical marijuana products are made with the safeguards above in mind, and those products are then administered using enabling tools such as the IoT dose-measuring devices manufactured by RYAH Group Inc. (CSE: RYAH), users are likely to have better outcomes than if they were using random ways to determining the right dosage of their plant medicines.

NOTE TO INVESTORS: The latest news and updates relating to RYAH Group Inc. (CSE: RYAH) are available in the company’s newsroom at https://cnw.fm/RYAH

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — Mainstream Companies Want In on Growing CBD Sector

When the 2018 farm bill legalized the cultivation and sale of industrial hemp and its derivatives, it opened the floodgates on an extremely lucrative market. With less than five years of legal sales under its belt, the hemp-derived cannabidiol (“CBD”) sector has seen hundreds of millions of dollars’ worth of product sales. Extracted from hemp, CBD is said to be chock full of potent and versatile medicinal properties and consumers have been purchasing CBD products in droves to reportedly help alleviate issues such as anxiety, chronic pain, and insomnia, among others.

According to a Grand View Research report, the CBD market was estimated to be worth $1.64 billion in 2020 and is poised to hit $13.9 billion by 2028. Unsurprisingly, mainstream supplement companies are throwing their hats into the ring to cash in on CBD as it becomes even more lucrative in the next few years. Plenty of companies are already producing CBD-infused foods, beverages, and nutritional supplements, even though the farm bill didn’t explicitly allow the infusion of CBD into edible products, and their bottom lines have piqued the interest of mainstream companies.

Several of them have even begun consulting with former mainstream packaged goods professionals. Aurora Cannabis appointed Nelson Peltz, Proctor & Gamble (“P&G”) Co. director, as a strategic advisor while Ignite International Ltd hired Curtis Hefferenan, a former P&G executive as the global head of sales.

Aside from its medical benefits, consumers are also drawn to CBD because it is not psychotropic, unlike THC (delta-9 tetrahydrocannabinol). Although hemp is in the cannabis family, it contains limited amounts of THC, the cannabinoid responsible for marijuana’s intoxicating effects. Consequently, hemp-extracted CBD will not intoxicate you as marijuana would. Furthermore, CBD’s versatility allows it to be infused into a wide variety of products, allowing customers who aren’t a fan of one product type, say tinctures, for example, to choose tablets or even topicals instead. With people becoming more aware of the adverse side effects of pharmaceuticals, alternative health and wellness products, such as those containing CBD, have seen a surge in popularity.

Nevada-based Grove, Inc. (NASDAQ: GRVI) is banking on CBD’s growing popularity as a health and wellness product. After its initial public offering (“IPO”) back in June where the company raised around $11 million in capital, Grove has been working to become the top producer of CBD-infused nutritional supplements. The capital allowed Grove to purchase VitaMedica, an online nutritional supplement seller, to capture a share of the global nutraceuticals market. Only time will tell if Grove’s gamble on CBD will pay out.

Companies that seem to be doing well in the growing CBD space include The Alkaline Water Company Inc. (NASDAQ: WTER) (CSE: WTER), which has established its footprint across the United States and is working with major retail chains.

NOTE TO INVESTORS: The latest news and updates relating to The Alkaline Water Company Inc. (NASDAQ: WTER) (CSE: WTER) are available in the company’s newsroom at http://cnw.fm/WTER

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CannabisNewsBreaks – The Alkaline Water Company Inc. (NASDAQ: WTER) (CSE: WTER) Announces Preliminary Q2 2022 Results

The Alkaline Water Company (NASDAQ: WTER) (CSE: WTER), the country’s largest independent alkaline water company and The Clean Beverage Company(TM), today announced that it anticipates topline revenue of approximately $15 million for the second quarter of fiscal year 2022. According to the update, this would be the best quarter on record and represent almost 50% year-over-year growth. In addition, the company reiterates full fiscal year 2022 revenue guidance of $62 million and will officially report its results for the full second quarter of fiscal year 2022 in November. “We anticipate the second quarter sales of fiscal 2022 will be a record and will represent our 34th straight comparable quarter of record growth,” said Ricky Wright, president and CEO of The Alkaline Water Company. “It is now clear to us that our ability to increase production capacity through new co-packers and raw material manufacturers is creating new business opportunities. Just like last year, we are meeting demand when others cannot. This year, we have seen tremendous growth of our single-serve Alkaline88(R) SKUs. Recent wins like Sam’s Club, Giant Food, new SKUs at CVS, United Pacific convenience stores, and adding nine of the largest airports in the country have positioned us to continue significant growth. Another measure of growth is quarterly purchase orders which have steadily increased this year and set a new record in Q2 fiscal 2022. The momentum seems to be continuing in the current quarter.”

To view the full press release, visit https://cnw.fm/CwOyr

About The Alkaline Water Company

The Alkaline Water Company is The Clean Beverage Company(TM) making a difference in the water you drink and the world we share. Founded in 2012, The Alkaline Water Company is headquartered in Scottsdale, Arizona. Its flagship product, Alkaline88(R), is a leading premier alkaline water brand available in bulk and single-serve sizes along with eco-friendly aluminum packaging options. With its innovative, state-of-the-art proprietary electrolysis process, Alkaline88 delivers perfect 8.8 pH-balanced alkaline drinking water with trace minerals and electrolytes and boasts its trademarked label: Clean Beverage. Quickly being recognized as a growing lifestyle brand, The Alkaline Water Company created the A88 Infused Beverage Division in 2018 to meet consumer demand for flavor-infused products under the A88 Infused(TM) brand. A88 Infused flavored water is available in six unique all-natural flavors, with new flavors coming soon. In 2021, The Alkaline Water Company was pleased to welcome Shaquille O’Neal to its board of advisors and to serve as the celebrity brand ambassador for the Alkaline88 and A88 Infused brands. To purchase Alkaline88 and A88 Flavor Infused products online, visit www.Alkaline88.com. To learn more about the company, visit www.TheAlkalineWaterCo.com.

NOTE TO INVESTORS: The latest news and updates relating to WTER are available in the company’s newsroom at http://cnw.fm/WTER

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Featured in ‘Stock2Me’ Podcast

Lexaria Bioscience Corp. (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, was featured in the latest episode of the “Stock2Me Podcast,” an IBN (InvestorBrandNetwork) solution to provide specialized content distribution via widespread syndication channels. Lexaria’s CEO and Chairman Chris Bunka joined the latest episode to discuss the company’s business model, his professional background and the team behind Lexaria, as well as the company’s recent transformative steps to position it for accelerated growth. “Our company kind of had a rebirth in January 2021. … We completed a 1-for-30 reverse stock split,” Bunka explained. “That was really hard, and just so you all know, I was the biggest shareholder. I am still the biggest shareholder. I took a big hit on my own holdings, but we had to do that to make the company attractive for future shareholders. … We got listed on Nasdaq in January and completed an $11 million financing. That was the biggest financing in the history of the company, and it transformed us. … We were able to step on the gas pedal and basically work on our research and development and our commercial studies at a 5-10x higher pace than anything we could do in the past. Therefore, this year, we’ve done more work than we did in the five years previous — all put together.”

To view the full press release, visit https://cnw.fm/eHvT6

About Lexaria Bioscience Corp.

Lexaria Bioscience Corp.’s patented drug delivery technology, DehydraTECH(TM), improves the way active pharmaceutical ingredients (“APIs”) enter the bloodstream by promoting more effective oral delivery. Since 2016, DehydraTECH has repeatedly demonstrated the ability to increase bio-absorption with cannabinoids and nicotine by up to 5-10x, reduce time of onset from 1-2 hours to minutes and mask unwanted tastes; it is also being evaluated for orally administered anti-viral drugs, non-steroidal anti-inflammatory drugs (“NSAIDs”) and more. DehydraTECH has also evidenced an ability to deliver some drugs more effectively across the blood brain barrier. Lexaria operates a licensed in-house research laboratory and holds a robust intellectual property portfolio with 21 patents granted and over 50 patents pending worldwide. For more information, visit the company’s website at www.LexariaBioscience.com.

NOTE TO INVESTORS: The latest news and updates relating to LEXX are available in the company’s newsroom at https://cnw.fm/LEXX

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) Subsidiary Receives Cannabis Cultivation License, Commences Grow Operations

Red White & Bloom (CSE: RWB) (OTCQX: RWBYF), a multistate cannabis operator and house of premium brands, announced that its subsidiary, Red White & Bloom Florida LLC, has received approval to begin growth operations at its 45,000-square-foot greenhouse in Apopka, Florida. The company has completed phase one of its cultivation strategy and is in the midst of a three-phase development plan for two Florida cultivation centers. The centers are part RWBYF’s plan to produce adequate inventory for existing and new dispensary openings planned for Q1 2022. The company had plants at the greenhouse ready to plant as soon as approval was receive; the growth operations began on Sept. 30, 2021. According to the announcement, projected flower production at the Apopka-licensed facility is 85 g per plant, or almost 10,000 pounds of dried flower per year, with projected annual revenue of more than $10 million. Phase three of Red White & Bloom’s Florida launch is the planned activation of its 113,000-square-foot indoor grow facility in Sanderson, Florida. “We brought this site into production ahead of forecast and ahead of budget, and I’m very proud of our Florida team,” said Red White & Bloom CEO Brad Rogers in the press release. “Despite being relatively new players in the Florida market, I feel we have the most talented team of PhDs and horticulturalists, and an incredible grow infrastructure to bring the highest quality products, rich in terpenes and cannabinoid content, to some of the best retail locations in the state starting in Q1 2022.”

To view the full press release, visit https://cnw.fm/rIKpU

About Red White & Bloom Brands Inc.

Red White & Bloom Brands is positioning itself to be one of the top-three, multistate cannabis operators active in the U.S. legal cannabis and hemp sector. RWB is predominantly focusing its investments on major U.S. markets, including Michigan, Illinois, Florida, Arizona and California, with respect to cannabis, as well as the United States and internationally for hemp-based CBD products. For more information about the company, please visit www.RedWhiteBloom.com

NOTE TO INVESTORS: The latest news and updates relating to RWBYF are available in the company’s newsroom at https://cnw.fm/RWBYF

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

420 with CNW — Key Mexican Senator Outlines Cannabis Legalization Steps

Three years ago, the Supreme Court in Mexico ruled that the country’s ban on cannabis consumption was unconstitutional, ending decades of cannabis prohibition and requiring that lawmakers reform cannabis laws. Mexico’s Congress was granted a deadline to repeal prohibitionist cannabis policies, now considered unconstitutional, but policymakers failed to do so within the allotted time. Both chambers of Congress spent months discussing and working on a legalization bill, repeatedly asking the court to extend the deadline.

Last year, the Senate passed a bill and sent it to the Chamber of Deputies, which made revisions and sent it back. However, after a few Senate committees took up and cleared the amended measure, some leaders stated that the amendments made the legislation unworkable. This June, three years after the Supreme Court first declared that cannabis prohibition in the country was illegal, the Senate voted to put an end to prohibition on its own after lawmakers failed to act in time. However, since all the top court did was decriminalize cannabis, the country still did not have regulations for legally sanctioned sales.

Now a top Mexican senator has indicated that lawmakers may finally pass a cannabis legalization bill during the new session. During a press conference, Senate Majority Leader Ricardo Monreal Avila said that lawmakers plan on filling this gap, which is the lack of regulations, during this session. They have a chance to deliberate upon and approve the “long-overdue law,” he says, ending a century of cannabis prohibition and criminalization. The legislation would in turn open the country to a nationwide and international multimillion dollar market and help to reactivate Mexico’s economy.

The cannabis legislation passed by the Senate may need further revisions before it is ready for passing during this session, Avila noted, including modifications to tax collection frameworks. Both chambers need to strive to create a bill that guarantees the freedoms and rights of all people involved, eradicate discriminatory treatment, in addition to “solve possible ambiguities,” says Monreal. Back in April, he urged lawmakers not to allow commercial interests, especially the tobacco and pharmaceutical industries, to pressure them to prematurely pass a bill, stating that it was important they take their time to formulate an equitable and socially conscious bill.

But Senator Eduardo Ramirez Aguilar from Morena said at the time that lawmakers should pass the bill as it was presented to them and work on fine-tuning it later through additional revisions. As it is, the cannabis legalization proposal allows adults who are at least 18 years old to purchase as well as possess a maximum of 28 grams of cannabis as well as grow up to six plants for their personal use.

For internationally focused cannabis companies such as Flora Growth Corp. (NASDAQ: FLGC), the developments in nearby Mexico could be of great interest since they have the potential to impact the dynamics of the international marijuana industry.

NOTE TO INVESTORS: The latest news and updates relating to Flora Growth Corp. (NASDAQ: FLGC) are available in the company’s newsroom at https://cnw.fm/FLGC

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — Congresswoman Previews Hemp Legislation That Will Ease Industry Restrictions

Hemp was federally legalized under the 2018 Farm Bill, which allowed farmers to begin growing this multifaceted crop. However, Congressional legislators are still working on changes to laws which govern the crop. Recently, Rep. Chellie Pingree previewed a bill that would ease restrictions on this flourishing industry.

The bill, called the Hemp Advancement Act, includes a provision that will remove a ban that prevents individuals with felony drug convictions that date back to the last decade from acquiring a business license for the crop or participating in the market. Pingree stated that the provision disproportionately excluded people of color from taking part in this burgeoning market. She explained that the measure’s intention was to make the U.S. Department of Agriculture’s (“USDA”) rules more workable for both processors and growers.

The legislation also seeks to increase the hemp and hemp extracts threshold for THC. Under the federal statute, hemp is defined as containing not more than 0.3% THC. This amount may sometimes increase during the process of production, which may cause issues for businesses involved in the industry. The legislation would offer relevant safeguards against this.

In addition to this, the measure would eliminate a USDA requirement that states that the crop should only be tested at labs registered with the United State Drug Enforcement Agency (“DEA”). Stakeholders have been calling for this reform for quite some time, arguing that this requirement will create bottlenecking of hemp testing, which may hold this burgeoning industry back.

Earlier in the year, Reps. Morgan Griffith and Kurt Schrader filed a separate legislation calling for  CBD derived from hemp and hemp to be sold as dietary supplements. This is another source of controversy, given that the present lack of regulations from the FDA is seen as a barrier for the industry’s growth.

In the Senate, Sens. Jeff Merkley, Rand Paul and Ron Wyden also filed a measure that would exempt CBD derived from hemp, hemp and substances that contain any ingredient derived from hemp from restrictions which have hindered the emergence of legal consumable hemp products. Additionally, Paul introduced a separate initiative in earlier this year that would increase the concentration of THC that hemp can legally contain by three times while also addressing other issues the industry has highlighted about the federal regulations.

Legislators have been pressuring the FDA to adopt new regulations that would provide for such since hemp was federally legalized.

For hemp/CBD focused companies such as Simply Sonoma Inc., any changes to the existing hemp laws could have immediate effects.

NOTE TO INVESTORS: The latest news and updates relating to Simply Sonoma Inc. are available in the company’s newsroom at https://cnw.fm/Sonoma

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.